The World Health Organization (WHO) supported the use of Astragenica Against him Coronavirus For people over 65 years of age, despite previous doubts about its effectiveness.

Mexican said, “The vaccine can be administered from the age of 18, without the maximum age limit, so it can also be given to people over 65 years of age.” Alejandro CreviottoIn a press conference organized by the WHO, chair of the Strategic Advisory Group (SAGE) of Experts on Immunization.

The expert acknowledged that clinical trials of the vaccine, developed by the Swedish-British pharmaceutical company in conjunction with the University of Oxford, had a minority participation of people over 65 years of age, contributing to skepticism about its efficacy. Could do. Age group., But the SAGE analysis concludes that “The results of these people are no different from youth groups.”

This was announced after several European countries decided not to apply the vaccine to people over 65 years of age. lack of information On its effectiveness and safety.

Commentary, that Britain It was the first to administer En Masse in December, it had already been approved by other countries and the European Union.

However, due to the lack of data on its efficacy in older populations, Some governments have decided to recommend its use For people under 65, or even 55, like Spain.

Spain tied up with other countries Like Belgium and Italy, which set the same threshold for applying the AstraZeneca vaccine. The application for people up to 55 years of age was the criterion adopted by the European Medicine Agency (EMA). However, countries such as Germany or France decided to vaccinate citizens up to 65 years old.

Initial trials of AstraZeneca were performed in people between 18 and 55 years old, and only months later, others between the ages of 56 and 69 were included, so its efficacy in the latter group was considered by some agencies Not tested with required robustness.

However, the scientific community says this does not mean that the vaccine is not safe, but more tests are needed to show that it is effective in people over 55 years of age.

Argentina is expected to receive 1.2 million doses of the Oxford-AstraZeneca vaccine between February and March. Before the end of the month, 580 thousand doses will come, While the rest will arrive in March.

This item is extra 22.4 million doses that the government agrees with AstraZeneca. It should be remembered that the country participates in the preparation of the vaccine. The production process begins here, complete in Mexico, where the vaccine is divided and packaged.

LGP